Search

Your search keyword '"Corradini, Stefanie"' showing total 974 results

Search Constraints

Start Over You searched for: Author "Corradini, Stefanie" Remove constraint Author: "Corradini, Stefanie"
974 results on '"Corradini, Stefanie"'

Search Results

1. SynthRAD2025 Grand Challenge dataset: generating synthetic CTs for radiotherapy

4. FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls

5. Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).

10. Präoperative Radiotherapie versus postoperative Radiotherapie nach neoadjuvanter Chemotherapie („NeoRad“) beim Hochrisikomammakarzinom: eine prospektive, randomisierte, internationale multizentrische Phase-III-Studie

11. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

17. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer

19. CloverNet – Leveraging Planning Annotations for Enhanced Procedural MR Segmentation: An Application to Adaptive Radiation Therapy

21. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group

22. Semi-automated reproducible target transfer for cardiac radioablation – A multi-center cross-validation study within the RAVENTA trial

25. Principles of oncology taught in a one-week course

26. Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization

27. Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)

29. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases

32. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich

36. Breast Cancer

39. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)

44. Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

50. Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis

Catalog

Books, media, physical & digital resources